Formulations including 5-(3-(3-hydroxyphenoxy)azetidin-1-yl)-5-methyl-2,2-diphenylhexanamide
Powder formulations for use in dry powder inhalers and methods of making them are provided. A powder formulation can include from about 0.01% to about 90% by weight of a carboxamide compound comprising 5-[3-(3-Hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2- diphenyl-hexanamide or a pharmaceutically acce...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
02.02.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!